Sensus Healthcare Inc

Sensus Healthcare Inc maintains a strong liquidity position, with a current ratio of 9.85 and $14.73 million in cash and equivalents, indicating a robust ability to meet short-term obligations. The company has no long-term debt, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with minimal leverage. The price-to-book ratio of 1.16 and price-to-tangible-book ratio of 1.16 indicate that the company's market value is slightly above its book value, reflecting investor confidence in its asset base.

In terms of profitability, Sensus Healthcare Inc reported a net income of $2.27 million and an operating income of $2.89 million, with a return on equity of 4.44% and a return on assets of 3.97%. These figures are in line with the industry's preferred metrics, which emphasize operational efficiency and asset utilization. The company's gross profit of $6.66 million and operating margin of 27.1% (calculated from operating income and revenue) suggest a healthy margin structure, although the exact cohort median for the industry is not provided.

Geographically and segment-wise, the company's revenue concentration is not explicitly detailed in the available data. However, the absence of disclosed geographic or segment breakdowns implies a potentially diversified or single-segment business model. The company's primary revenue stream is derived from the healthcare equipment sector, with no significant diversification into other areas.

Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year. The current fiscal year's revenue of $10.66 million is expected to remain relatively flat, with no substantial growth or decline anticipated. The company's free cash flow of $2.11 million and capital expenditure of $233,000 indicate a balanced approach to reinvestment and cash generation.

The risk assessment for Sensus Healthcare Inc indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves contribute to its favorable risk profile. Additionally, the absence of dilution potential in both basic and diluted shares suggests that the company is not currently issuing new shares to raise capital, which is a positive sign for existing shareholders.

Recent events and filings do not show any significant developments that would impact the company's operations or financial health. The company's financial statements and disclosures are consistent with a stable and well-managed business, with no major red flags or unexpected liabilities reported.

Analysts project 124.7% upside to a mean price target of $6.875, signaling strong institutional confidence in future valuation recovery.

The company maintains zero long-term debt, providing a pristine balance sheet that eliminates interest expense and refinancing risks entirely.

Operating and net margins rank in the top quartile of the Advanced Medical Equipment cohort, demonstrating superior profitability efficiency.

A current ratio of 9.72 indicates exceptional short-term liquidity, ensuring the firm can easily meet immediate financial obligations.

Risk flags for dilution, liquidity, and credit are all rated low, suggesting a stable operational environment with minimal immediate threats.

Cash conversion ranks in the bottom quartile of its peer cohort, highlighting inefficiencies in generating cash from operations.

Revenue $4.9M, −62,2% YoY; Operating income −282,4% YoY.

• ▍Revenue $4.9M, −62,2% YoY
• ▍Operating income −282,4% YoY
• ▍Net income −304,9% YoY
• ▍Free cash flow −266,4% YoY
• ▍Net margin -64.1%

Revenue $6.9M, −22,1% YoY; Operating income −271,8% YoY.

• ▍Revenue $6.9M, −22,1% YoY
• ▍Operating income −271,8% YoY
• ▍Net income −177,6% YoY
• ▍Free cash flow −191,2% YoY
• ▍Net margin -13.7%

Revenue $7.3M, −20,8% YoY; Operating income −198,0% YoY.

• ▍Revenue $7.3M, −20,8% YoY
• ▍Operating income −198,0% YoY
• ▍Net income −164,3% YoY
• ▍Free cash flow −158,8% YoY
• ▍Net margin -14.2%

Revenue $8.3M, −21,8% YoY; Operating income −191,7% YoY.

• ▍Revenue $8.3M, −21,8% YoY
• ▍Operating income −191,7% YoY
• ▍Net income −213,1% YoY
• ▍Free cash flow −218,1% YoY
• ▍Net margin -30.8%

Revenue $13.1M; Operating income $1.7M.

• ▍Revenue $13.1M
• ▍Operating income $1.7M
• ▍Net margin 11.8%

Revenue $8.8M; Operating income $1.5M.

• ▍Revenue $8.8M
• ▍Operating income $1.5M
• ▍Net margin 13.7%

Revenue $9.2M; Operating income $2.0M.

• ▍Revenue $9.2M
• ▍Operating income $2.0M
• ▍Net margin 17.4%

Revenue $10.7M; Operating income $2.9M.

• ▍Revenue $10.7M
• ▍Operating income $2.9M
• ▍Net margin 21.3%

Revenue $27.5M, −34,3% YoY; Operating income −227,4% YoY.

• ▍Revenue $27.5M, −34,3% YoY
• ▍Operating income −227,4% YoY
• ▍Net income −216,1% YoY
• ▍Free cash flow −210,7% YoY
• ▍Net margin -28.1%

Revenue $41.8M, +71,3% YoY; Operating income +2 217,8% YoY.

• ▍Revenue $41.8M, +71,3% YoY
• ▍Operating income +2 217,8% YoY
• ▍Net income +1 270,5% YoY
• ▍Free cash flow +1 144,8% YoY
• ▍Net margin 15.9%

Revenue $24.4M, −45,2% YoY; Operating income −102,6% YoY.

• ▍Revenue $24.4M, −45,2% YoY
• ▍Operating income −102,6% YoY
• ▍Net income −98,0% YoY
• ▍Free cash flow −97,8% YoY
• ▍Net margin 2.0%

Revenue $44.5M, +64,7% YoY; Operating income +260,0% YoY.

• ▍Revenue $44.5M, +64,7% YoY
• ▍Operating income +260,0% YoY
• ▍Net income +488,6% YoY
• ▍Free cash flow +430,0% YoY
• ▍Net margin 54.4%